Opioids and rate of positively reinforced behavior: III. Antagonism by the long-lasting kappa antagonist norbinaltorphimine

Behavioural Pharmacology

Volumn 7, Issue 6, 1996, Pages 495-504

  Picker, M J ^a   Mathewson, C ^a   Allen, R M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

bremazocine; kappa opioid antagonism; kappa opioids; norbinaltorphimine; rat; response rate; schedule controlled responding

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ANGIOTENSIN; BREMAZOCINE; CYCLAZOCINE; ETHYLKETAZOCINE; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; N ALLYLNORMETAZOCINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALORPHINE; NORBINALTORPHIMINE; OPIATE; SPIRADOLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; FOOD; INSTRUMENTAL CONDITIONING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; REINFORCEMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030472376     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bergman J and Warren PH (1989) Effects of kappa opioids on schedule-controlled behavior in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 248, 1102-1108.
2. Broadbear JH, Negus SS, Butelman ER, de Costa BR and Woods JH (1994) Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on κ-opioid agonists in the mouse writhing assay. Psychopharmacology, 115, 311-319.
3. Butelman ER, Negus SS, AI Y, de Costa BR and Woods JH (1993) Kappa opioid antagonist effects of systematically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 267, 1269-1276.
4. Craft R, Picker MJ and Dykstra LA (1989) Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation. Journal of Pharmacology and Experimental Therapeutics, 249, 386-393.
5. Eisenberg RM (1985) The occurrence of cross-tolerance between morphine and ethylketocyclazocine using the tail-flick test: Lack of effect of diazepam, phenobarbital, or amphetamine. Life Science, 37, 915-922.
6. Emmerson PJ, Liu M-R, Woods JH and Medzihradsky F (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. Journal of Pharmacology and Experimental Therapeutics, 271, 1630-1637.
7. Endoh T, Matsuura H, Tanaka C and Nagase H (1992) Norbinaltorphimine: A potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo. Archives of International Pharmacodynamics, 316, 30-42.
8. France CP and Woods JH (1985) Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon. Journal of Pharmacology and Experimental Therapeutics, 235, 442-447.
9. France CP, Medzihradsky F and Woods JH (1994) Comparison of kappa opioids in rhesus monkeys: Behavioral effects and receptor binding affinities. Journal of Pharmacology and Experimental Therapeutics, 268, 47-58.
10. Harris RA (1980) Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior. Journal of Pharmacology and Experimental Therapeutics, 213, 497-503.
11. Hayes AG, Skingle M and Tyers MB (1987) Evaluation of the receptor selectivities of opioid drugs by investigating the block of the effect on urine output by β-funaltrexamine. Journal of Pharmacology and Experimental Therapeutics, 240, 984-988.
12. Horan P, Taylor J, Yamamura HI and Porreca F (1992) Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. Journal of Pharmacology and Experimental Therapeutics, 260, 1237-1243.
13. Howell LL, Bergman J and Morse WH (1988) Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 245, 365-372.
14. Jewett DC and Woods JH (1995) Nor-binaltorphimine: An ultra-long acting kappa opioid antagonist in pigeons. Behavioural Pharmacology, 6, 815-820.
15. Jones DNC and Holtzman SG (1992) Long term κ-opioid receptor blockade following nor-binaltorphimine. European Journal of Pharmacology, 215, 345-348.
16. Katz JL (1987) Effects of ethylketocyclazocine and morphine alone and in combination with naloxone on schedule-controlled behavior in pigeons. Psychopharmacology, 92, 508-512.
17. Leander JD (1983) A kappa opioid effect: Increased urination in the rat. Journal of Pharmacology and Experimental Therapeutics, 224, 89-94.
18. Locke KW, Gorney B, Cornfeldt M and Fielding S (1989) Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat. Psychopharmacology, 99, 492-496.
19. Mattox AJ, Picker MJ and Dykstra LA (1993) Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons. Psychopharmacology, 113, 457-462.
20. McMillan DE, Wolf PS and Carchman RA (1970) Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon. Journal of Pharmacology and Experimental Therapeutics, 175, 443-458.
21. Moerschbaecher JM, Brocklehurst C, Devia C and Faust WB (1987) Effects of kappa agonists and dexoxadrol on the acquisition of conditional discriminations in monkeys. Journal of Pharmacology and Experimental Therapeutics, 243, 737-744.
22. Moerschbaecher JM, Devia C and Brocklehurst C (1988) Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats. Journal of Pharmacology and Experimental Therapeutics, 244, 237-246.
23. Negus SS, Burke TF, Medzihradsky F and Woods JH (1993) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: Antagonism by quadazocine. Journal of Pharmacology and Experimental Therapeutics, 267, 896-903.
24. 3H]ethylketocyclazocine. Life Science, 42, 2403-2412.
25. Paronis CA, Waddell AB and Holtzman SG (1993) Naltrexone in vivo protects μ receptors from inactivation by β-funaltrexamine, but not κ receptors from inactivation by norbinaltorphimine. Pharmacology, Biochemistry and Behavior, 46, 813-817.
26. Picker MJ (1994a) Discriminative stimulus and response rate-decreasing effects of kappa opioids: Antagonism by naloxone. Life Science, 54, 1767-1775.
27. Picker MJ (1994b) Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure. Journal of Pharmacology and Experimental Therapeutics, 268, 1190-1198.
28. Picker MJ (1995) Assessment of the kappa agonist and antagonist properties of mixed action opioids, mu opioids, and a delta opioid in pigeon. Experimental and Clinical Psychopharmacology, 3, 240-251.
29. Picker MJ, Negus SS and Powell KR (1990) Differential cross tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation. Psychopharmacology, 103, 129-135.
30. Picker MJ, Yarbrough J, Hughes CE, Smith MA, Morgan D and Dykstra LA (1993) Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: Role of training dose, intrinsic efficacy and inter-animal differences. Journal of Pharmacology and Experimental Therapeutics, 266, 756-767.
31. Pitts RC, West JP, Morgan D, Dykstra LA and Picker MJ (1996) Effects of opioids on positively reinforced behavior: Differential antagonism by naltrexone. Behavioural Pharmacology, 7, 205-215.
32. Porreca F, Cowan A, Raffa RB and Tallarida FJ (1982) Tolerance and cross-tolerance studies with morphine and ethylketocyclazocine. Journal of Pharmacy and Pharmacology, 34, 666-667.
33. Shannon HE (1982) Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats. Journal of Pharmacology and Experimental Therapeutics, 222, 146-151.
34. Shearman GT and Herz A (1981) Discriminative stimulus properties of bremazocine in the rat. Neuropharmacology, 20, 1209-1213.
35. Snell D and Harris AR (1982) Interactions between narcotic agonist, partial agonists and antagonists evaluated by punished and unpunished behavior in the rat. Psychopharmacology, 76, 177-181.
36. Smith MA and Picker MJ (1995) Examination of the discriminative stimulus effects of kappa opioids and mixed action opioids in rats: Influence of training dose and intrinsic efficacy. Behavioural Pharmacology, 6, 703-717.
37. Spanagel R, Almeida OFX, Shippenberg TS (1994) Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. European Journal of Pharmacology, 264, 157-162.
38. Takemori AE, Ho BY, Naeseth JS and Portoghese PS (1988) Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. Journal of Pharmacology and Experimental Therapeutics, 246, 255-258.
39. Tang AH and Code RA (1983) Discriminative stimulus properties of nalorphine in the rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics, 227, 563-569.
40. Tiberi M and Magnan J (1990) Quantitative analysis of multiple κ-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: Resolution of high and low affinity states of the κ2 receptors by computerized model-fitting technique. Molecular Pharmacology, 37, 694-703.
41. Wolleman M, Sandor B and Simon J (1993) The kappa-opioid receptor: Evidence for the different subtypes. Life Science, 52, 599-611.
42. Young AM and Stephens KR (1984) Antagonism of the discriminative effects of ethylketocyclazocine, cyclazocine, and nalorphine in macaques. Psychopharmacology, 84, 356-361.
43. Young AM and Woods JH (1982) Limitations on the antagonistic actions of opioid antagonists. Federation Proceedings, 41, 2333-2338.